These studies suggest that ATM mutations causing AT but not other ATM variants are associated with increased breast cancer risk in heterozygous carriers and that this risk may be increased by radiation exposure; however, these results await replication, and current guidelines do not recommend that heterozygous ATM mutation carriers should avoid radiation. The gene discussed is ATM; the disease is breast carcinoma.